|Bid||21.46 x 4000|
|Ask||21.61 x 3100|
|Day's range||21.41 - 22.43|
|52-week range||15.41 - 60.50|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||08 Nov 2022 - 14 Nov 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||33.95|
Online dating specialist Match Group (NASDAQ: MTCH) has had a rough go of it over the past year. Following a pandemic-related boom, the tech company's revenue growth has slowed. When also considering market-wide problems such as inflation and company-specific issues (more on that later), it's not surprising that Match Group stock now finds itself near its 52-week low as of this writing.
Investors are also scaling back the premiums they're willing to pay for stocks. As a result, many high-priced growth stocks have come down in valuation. Three Nasdaq stocks that took a beating last month are Novavax (NASDAQ: NVAX), Tandem Diabetes Care (NASDAQ: TNDM), and Bumble (NASDAQ: BMBL).
Investors need to pay close attention to Bumble (BMBL) stock based on the movements in the options market lately.